TOPBP1 and pancreatic neoplasm: Collectively, these results demonstrated that in a subcutaneously implanted xenograft mouse model, olaparib effectively suppressed the growth of pancreatic cancer cells following Topbp1 knockdown in Patu8988 cells characterized by high Topbp1 expression.